Filing Details

Accession Number:
0001140361-14-011987
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-10 18:16:15
Reporting Period:
2014-03-06
Filing Date:
2014-03-10
Accepted Time:
2014-03-10 18:16:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.,
105 Digital Drive
Novato CA 94949
Svp, Chief Commercial Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-06 2,558 $21.51 27,938 No 4 M Direct
Common Stock Acquisiton 2014-03-06 14,812 $28.23 42,750 No 4 M Direct
Common Stock Disposition 2014-03-06 17,370 $78.63 25,380 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2014-03-06 2,558 $0.00 2,558 $21.51
Common Stock Common Stock Disposition 2014-03-06 14,812 $0.00 14,812 $28.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,125 2010-11-12 2020-05-11 No 4 M Direct
5,258 2011-12-01 2021-05-30 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $77.48 to $79.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Original option grant vests 6/48th on November 12, 2010 and 1/48th on the 12th of each month thereafter.
  4. Original option grant vests 6/48th on December 1, 2011 and 1/48th on the 1st of each month thereafter.
  5. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.